The DOI matches its Crossref record.
CD95–CD95L: can the brain learn from the immune system?
Abstract
Members of the tumor necrosis factor/nerve growth factor receptor superfamily of cell-surface molecules can play the dual role of mediating either cytotoxicity or cell survival, both in the immune system and in the nervous system. A member of this superfamily, CD95 (also known as ApoI or Fas), was initially identified in the immune system and has been shown to mediate receptor-dependent programmed cell death and to be expressed in the nervous system. In neurodegenerative disorders, CD95-CD95 ligand expression on glial cells might precede receptor-mediated apoptosis by cells of the CNS. It is now being recognized that CD95 signaling by immune cells mediates effects other than apoptosis, such as cell survival and under inflammatory conditions expression of this protein promotes neural-immune interactions. Both neuroscientists and immunologists can contribute to defining the mechanisms underlying these divergent effects and utilize such knowledge to aid understanding of cell death and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FASLG induces cell death by binding to its receptor FAS, leading to caspase-dependent apoptosis.
“FASLG induces cell death by binding to its receptor, FAS, leading to caspase-dependant apoptosis [16, 17].”
From MicroRNA‐21 protects neurons from ischemic death (2010) · cites this paper as [16]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 35
- Akbar, 1996, Eur. J. Immunol., 26, 294, 10.1002/eji.1830260204 · DOI
- Abbas, 1996, Cell, 84, 655, 10.1016/S0092-8674(00)81042-9 · DOI
- Nagata, 1997, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 · DOI
- Kaplan, 1994, J. Neurobiol., 25, 1404, 10.1002/neu.480251108 · DOI
- Dragunow, 1995, Brain Res. Rev., 21, 1, 10.1016/0165-0173(95)00003-L · DOI
- Ham, 1995, Neuron, 14, 927, 10.1016/0896-6273(95)90331-3 · DOI
- Frade, 1996, Nature, 383, 166, 10.1038/383166a0 · DOI
- Majdan, 1997, J. Neurosci., 17, 6988, 10.1523/JNEUROSCI.17-18-06988.1997 · DOI
- Mangan, 1991, J. Immunol., 146, 1541, 10.4049/jimmunol.146.5.1541 · DOI
- Bruce, 1996, Nature Med., 2, 788, 10.1038/nm0796-788 · DOI
- Liu, 1996, Cell, 87, 565, 10.1016/S0092-8674(00)81375-6 · DOI · Paper page
- Kayagaki, 1995, J. Exp. Med., 182, 1777, 10.1084/jem.182.6.1777 · DOI
- Muzio, 1996, Cell, 85, 817, 10.1016/S0092-8674(00)81266-0 · DOI · Paper page
- Schwartz, 1996, Trends Neurosci., 19, 555, 10.1016/S0166-2236(96)10067-9 · DOI
- Hsu, 1996, Cell, 84, 299, 10.1016/S0092-8674(00)80984-8 · DOI
- Natoli, 1997, Science, 275, 200, 10.1126/science.275.5297.200 · DOI
- Castro, 1996, Immunity, 5, 617, 10.1016/S1074-7613(00)80275-7 · DOI
- Park, 1996, Immunity, 4, 583, 10.1016/S1074-7613(00)80484-7 · DOI
- Piazza, 1997, J. Immunol., 158, 1503, 10.4049/jimmunol.158.4.1503 · DOI
- Nagata, 1995, Immunol. Today, 16, 39, 10.1016/0167-5699(95)80069-7 · DOI
- Dowling, 1996, J. Exp. Med., 184, 1513, 10.1084/jem.184.4.1513 · DOI
- D'Souza, 1996, J. Exp. Med., 184, 2361, 10.1084/jem.184.6.2361 · DOI
- Becher, B. et al. Neuroscience (in press)
- Nishimura, 1995, Brain Res., 695, 137, 10.1016/0006-8993(95)00699-Q · DOI
- Mogi, 1996, Neurosci. Lett., 220, 195, 10.1016/S0304-3940(96)13257-2 · DOI
- Alderson, 1994, Int. Immunol., 6, 1799, 10.1093/intimm/6.11.1799 · DOI
- Foote, 1996, J. Immunol., 157, 2749, 10.4049/jimmunol.157.7.2749 · DOI
- Cheng, 1994, Science, 263, 1759, 10.1126/science.7510905 · DOI
- Papoff, 1996, J. Immunol., 156, 4622, 10.4049/jimmunol.156.12.4622 · DOI
- Irmler, 1997, Nature, 388, 190, 10.1038/40657 · DOI
- Sato, 1995, Science, 268, 411, 10.1126/science.7536343 · DOI
- Ponton, 1996, J. Biol. Chem., 271, 8991, 10.1074/jbc.271.15.8991 · DOI
- Griffith, 1996, Immunity, 5, 7, 10.1016/S1074-7613(00)80305-2 · DOI · Paper page
- Hahne, 1996, Science, 274, 1363, 10.1126/science.274.5291.1363 · DOI
- Saas, 1997, J. Clin. Invest., 99, 1173, 10.1172/JCI119273 · DOI
Cited by
Sorted by citations
Kim, Y. S., & Joh, T. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.40 · Cited by 655
Vawter, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00377-2 · Cited by 275
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
MicroRNA‐21 protects neurons from ischemic death
Buller, B., Liu, X., Wang, X., Zhang, R. L., Zhang, L., Hozeska‐Solgot, A., Chopp, M., & Zhang, Z. G. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07818.x · Cited by 242
Metadata
- Authors
- Becher, B., Owens, T., Antel, J. P., & Barker, P. A.
- Affiliations
- Montreal Neurological Institute and Hospital (CA)
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 1998-03
- Volume
- 21
- Issue
- 3
- Pages
- 114-116
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2043639971
- Cited by
- 63
- References
- 0
- Citations by year
- 2023: 1 · 2016: 1 · 2015: 1
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Fas, Fas ligand, TNF receptor superfamily, apoptosis, cell survival, neurodegenerative diseases, glial cells, neuroimmune interactions, neuroinflammation, programmed cell death
- MeSH terms
- Brain, Humans, Immune System, Ligands, Apoptosis, fas Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review